Caplin Point Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 30-May-2025.

Corporate Actions View source PDF Explain this filing

CAPLIPOINT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹2017.90

prior close

₹1984.10

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.8%-1.5% vs market

Pharmaceuticals peers, median of 150sector+0.4%-1.2% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Smallcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.0

15m

-0.2

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+0.8-1.5+0.4-1.2

Next day

-0.7+2.3-3.0+0.9-1.6

+6.4+3.0+3.4+1.8+4.5

+5.8+2.1+3.7+1.1+4.6

+11.0+2.5+8.5+1.9+9.1

+12.8+2.5+10.4+1.8+11.0

+7.9+3.6+4.3+1.7+6.3

15d

+5.3+7.1-1.8+2.6+2.7

+3.5+7.8-4.3+2.6+0.9

+2.9+11.9-9.0+4.8-1.9

+6.6+5.2+1.4+0.0+6.6

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Caplin Point Laboratories approved an interim dividend of ₹3.00 per equity share (150% on face value of ₹2) for FY25, with May 30, 2025 fixed as the record date to determine eligible shareholders. The company also announced its audited FY25 results, reporting consolidated total revenue of ₹2,034 Crores (up 15.5% YoY) and profit after tax of ₹541 Crores (up 17.3% YoY). EBITDA grew 20.2% to ₹743 Crores with margins improving to 36.5%, while basic EPS rose 17.2% to ₹70.57. The company ended the year with strong cash reserves — free cash reserves of ₹1,180 Crores and total liquid assets of ₹2,148 Crores. The company also appointed M/s. M Alagar & Associates as Secretarial Auditors for a five-year term starting FY26.

Likely market impact

Positive for shareholders: The interim dividend rewards investors while the strong FY25 earnings — double-digit revenue and profit growth along with margin expansion and robust cash generation — signal healthy business momentum, likely to be viewed favorably by the market.